Skip to main content
PZ Cormay S.A. logo

PZ Cormay S.A. — Investor Relations & Filings

Ticker · CRM ISIN · PLCMRAY00029 LEI · 2594006HZJ8OSNK56U87 WAR Manufacturing
Open in API
Filings indexed 692 across all filing types
Latest filing 2019-05-13 M&A Activity
Country PL Poland
Listing WAR CRM

About PZ Cormay S.A.

https://cormaydiagnostics.com/

PZ Cormay S.A. is a manufacturer and distributor of in-vitro diagnostic (IVD) solutions for medical laboratories and clinics. The company develops, produces, and sells a comprehensive portfolio of diagnostic reagents, laboratory analyzers, and quality control systems. Its offerings cater to key diagnostic areas, including clinical chemistry, hematology, and immunoassay. Key product lines feature the Accent series of chemistry analyzers, the Auryx immunoassay system, and the Mythic family of hematology analyzers. The company integrates its extensive experience in reagent manufacturing with advanced Swiss hematology technology to provide reliable, high-performance, and cost-effective diagnostic tools to a global network of distributors and healthcare professionals.

Recent filings

Filing Released Lang Actions
Zawarcie umowy sprzedaży akcji (share purchase agreement) dotyczącej sprzedaży całego posiadanego przez Orphee SA pakietu akcji Diesse, zamknięcie transakcji i ujawnienie opóźnionej informacji pouf...
M&A Activity Classification · 99% confidence The document explicitly references 'raportów bieżących' (current reports) and cites Article 17 of Regulation (EU) No 596/2014 (MAR), which governs the disclosure of inside information. The text details a significant transaction (sale of shares in a subsidiary, Diesse) and discusses the justification for delaying the public disclosure of this 'Informacja Poufna' (Inside Information). This structure—a formal announcement referencing MAR and detailing a material event—is characteristic of mandatory regulatory disclosures in the EU/Polish market. Since it is a current report detailing a material event (M&A/Sale of subsidiary) and not a full annual report (10-K), interim report (IR), or a simple announcement of a report's publication (RPA), it falls best under the general category for regulatory filings that are not otherwise specified, or potentially a specific M&A filing if one existed. Given the provided options, 'Regulatory Filings' (RNS) is the most appropriate general category for mandatory, non-standardized regulatory disclosures like this, especially since the core content is the disclosure of inside information under MAR, rather than a specific financial statement or management discussion. However, since the content is clearly about a major transaction (sale of a subsidiary), 'M&A Activity' (TAR) is a strong candidate. Given the context of Polish regulatory filings (where 'Raport Bieżący' is the standard format for MAR disclosures), and the content being a major transaction, TAR is more specific than RNS. I will classify it as TAR because the core subject is the sale of a subsidiary via a Share Purchase Agreement (SPA).
2019-05-13 Polish
Kontynuowanie negocjacji w sprawie zbycia udziałów Diesse - Content (PL)
M&A Activity Classification · 98% confidence The document text, originating from PZ CORMAY S.A., discusses ongoing negotiations regarding the potential sale of shares in a subsidiary (Diesse Diagnostica Senese S.p.A.) to an interested party. It mentions extending an exclusivity period and confirms key terms of a potential transaction. This subject matter—proposals, negotiations, and potential transactions involving mergers, acquisitions, or takeovers—directly aligns with the definition of M&A Activity (TAR). The document is a substantive update on the transaction process, not merely an announcement that a report is available.
2019-04-29 Polish
Uzupełnienie raportu rocznego i skonsolidowanego raportu rocznego w zakresie informacji o stosowaniu ładu korporacyjnego - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal regulatory announcement from PZ Cormay S.A. regarding an update/supplement to their previously published 2018 annual reports. It specifically provides additional disclosures regarding corporate governance, the audit committee, and auditor independence, citing specific Polish regulatory requirements (Rozporządzenie Ministra Finansów). Since it is an announcement providing supplementary information to existing reports rather than the full annual report itself, and it serves as a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS). FY 2018
2019-04-26 Polish
Wypowiedzenie umowy o dofinansowanie - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document text describes a significant event where the company received notice from the Polish Agency for Enterprise Development (PARP) to terminate a subsidy agreement and repay PLN 3,180,683.32 plus interest. This involves a legal/regulatory dispute regarding government funding and subsequent financial adjustments (reclassification of liabilities in the 2018 financial statements). This type of material event concerning legal/regulatory action and financial implications fits best under the 'Legal Proceedings Report' (LTR) category, as it details a formal dispute and demand for repayment from a regulatory body, even though it references prior financial reports. It is not a full financial report (10-K or IR), an earnings release (ER), or a general regulatory filing (RNS).
2019-04-25 Polish
Sprawozdanie_Zarzadu_GK_PZ_Cormay_2018.pdf
Audit Report / Information Classification · 98% confidence The document is titled "Sprawozdanie Zarządu z działalności za rok zakończony 31 grudnia 2018" which translates to "Management Board Report on activities for the year ended December 31, 2018". The Table of Contents details comprehensive sections covering basic operations, management structure, capital, significant events, financial results (Income Statement, Balance Sheet, Cash Flow), sales, R&D, risk assessment, investments, and related party transactions. This structure is characteristic of a full annual report detailing the company's performance and activities over the fiscal year. Although the document is in Polish, the content strongly aligns with the scope of a 10-K (Annual Report), which covers the entire fiscal year's operations and financial status. FY 2018
2019-04-14 Polish
Sprawozdanie_z_badania_GK_PZ_Cormay_2018.pdf
Audit Report / Information Classification · 100% confidence The document is explicitly titled "Sprawozdanie niezależnego biegłego rewidenta z badania dla Zgromadzenia Akcjonariuszy PZ CORMAY S.A." (Report of the independent auditor on the audit for the General Meeting of Shareholders of PZ CORMAY S.A.) and further specifies it as a "Sprawozdanie z badania rocznego skonsolidowanego sprawozdania finansowego" (Report on the audit of the annual consolidated financial statements). It contains the formal 'Opinia' (Opinion) from the auditor (BDO) regarding the financial statements for the year ended December 31, 2018, referencing International Financial Reporting Standards (IFRS) and Polish auditing standards (KSB). This content perfectly matches the definition of an Audit Report/Information (AR), which covers standalone audit reports and applied accounting principles, distinguishing it from a full Annual Report (10-K) which contains the financial statements themselves, whereas this document is the *report on the audit* of those statements. FY 2018
2019-04-14 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.